Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Disease relapse is the major causes of treatment failure after allogeneic stem cell transplantation (SCT) in patients with acute myeloid leukemia (AML). As well as demonstrating significant clinical activity in AML, azacitidine (AZA) upregulates putative tumor antigens, inducing a CD8(+) T cell resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Craddock, Charles, Jilani, Nadira, Siddique, Shamyla, Yap, Christina, Khan, Josephine, Nagra, Sandeep, Ward, Janice, Ferguson, Paul, Hazlewood, Peter, Buka, Richard, Vyas, Paresh, Goodyear, Oliver, Tholouli, Eleni, Crawley, Charles, Russell, Nigel, Byrne, Jenny, Malladi, Ram, Snowden, John, Dennis, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carden Jennings Publishing 2016
Materias:
Brief Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728172/
https://www.ncbi.nlm.nih.gov/pubmed/26363443
http://dx.doi.org/10.1016/j.bbmt.2015.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728172/
https://www.ncbi.nlm.nih.gov/pubmed/26363443
http://dx.doi.org/10.1016/j.bbmt.2015.09.004

Ejemplares similares